Clinician prescription of lipid-lowering drugs and achievement of treatment goals in patients with newly diagnosed type 2 diabetes mellitus
Introduction Lipid control is essential in type 2 diabetes mellitus (T2DM). The aim of this study is to investigate factors associated with lipid therapy adherence and achievement of goals in real-life setting among patients with recently diagnosed T2DM.Research design and methods This is a longitud...
Main Authors: | Francisco J Gómez-Pérez, Arely López-Reyes, Fabiola Mabel Del Razo-Olvera, Karla Ivette Galaviz, Adriana Galván-Pérez |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-08-01
|
Series: | BMJ Open Diabetes Research & Care |
Online Access: | https://drc.bmj.com/content/9/1/e001891.full |
Similar Items
-
Nerve conduction abnormalities in patients with newly diagnosed diabetes mellitus
by: Aditya Prakash Kulkarni, et al.
Published: (2018-01-01) -
Neurophysiological evaluation in newly diagnosed Diabetes Mellitus type 1
by: Matanovic Dragana, et al.
Published: (2013-08-01) -
Early Glycosylated Hemoglobin Target Achievement Predicts Clinical Outcomes in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
by: Joonyub Lee, et al.
Published: (2021-07-01) -
Early Glycosylated Hemoglobin Target Achievement Predicts Clinical Outcomes in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
by: Joonyub Lee, et al.
Published: (2021-05-01) -
The professional liability of clinicians for off-label prescriptions
by: A. Zagari
Published: (2013-05-01)